Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD; Department of Psychiatry, School of Medicine, Johns Hopkins University, Baltimore, MD.
J Subst Abuse Treat. 2014 Feb;46(2):268-73. doi: 10.1016/j.jsat.2013.07.012. Epub 2013 Aug 29.
Barriers to both mental health and substance use disorder treatments have rarely been examined among individuals with comorbid mental health and substance use disorders. In a sample of 393 adults with 12-month major depressive episodes and substance use disorders, we compared perceived barriers to these two types of treatments. Data were drawn from the 2005-2011 U.S. National Surveys on Drug Use and Health. Overall, the same individuals experienced different barriers to mental health treatment versus substance use disorder treatment. Concerns about negative views of the community, effects on job, and inconvenience of services were more commonly reported as reasons for not receiving substance use disorder treatment. Not affording the cost of care was the most common barrier to both types of treatments, but more commonly reported as a barrier to mental health treatment. Improved financial access through the Affordable Care Act and parity legislation and integration of mental health and substance use disorder services may help to reduce treatment barriers among individuals with comorbid mental health and substance disorders.
在同时患有精神健康障碍和物质使用障碍的个体中，很少对两者的治疗都存在障碍的情况进行研究。在一项有 393 名成年人参与的为期 12 个月的重度抑郁症和物质使用障碍的研究样本中，我们对这两种治疗方式的障碍感知进行了比较。数据来自于 2005 年至 2011 年美国全国毒品使用与健康调查。总的来说，同样的个体在接受精神健康治疗和物质使用障碍治疗时经历了不同的障碍。对社区负面看法、对工作的影响和服务的不便等方面的担忧，更常被报告为未接受物质使用障碍治疗的原因。支付不起治疗费用是两种治疗方式的共同障碍，但更常被报告为精神健康治疗的障碍。平价医疗法案和均等立法改善了财务获取途径，以及精神健康和物质使用障碍服务的整合，可能有助于减少同时患有精神健康和物质障碍的个体的治疗障碍。
